Infantile and Juvenile-Onset Hypophosphatasia Treatment Market Poised to Incur Steadfast Growth During 2017-2025
The Hypophosphatasia (HPP) is a rare genetic disease caused by mutations in the ALPL gene. It is a metabolic disorder that effects multiple body systems and leads to life-threatening complications. This disease leads to abnormal development of the bones due to defective bone mineralization and can lead to rickets, tempering of the bones that result in different types of bone abnormalities. The sign and symptoms include soft bones, hypercalcemia, short stature and weak bones with loss of mobility, and may...
View full press release